To obtain help on using IRIS contact iris_support@ucl.ac.uk
For queries about the IRIS project please contact iris@ucl.ac.uk
IRIS FAQ (Frequently Asked Questions)
For queries about the IRIS project please contact iris@ucl.ac.uk
IRIS FAQ (Frequently Asked Questions)
Please report any queries concerning the funding data shown on the profile page to:
http://www.ucl.ac.uk/finance/secure/research/post_award
http://www.ucl.ac.uk/finance/secure/research/post_award
Please report any queries concerning the student data shown on the profile page to:
Email: studentrecords@ucl.ac.uk
Tel: 020 7679 7005 or 020 7679 7006 (Internal 37005 or 37006)
Email: studentrecords@ucl.ac.uk
Tel: 020 7679 7005 or 020 7679 7006 (Internal 37005 or 37006)

Browse IRIS
› More search options
Dr Rachel Batterham
Rayne Building
5 University Street
London
WC1E 6JJ
Tel: 020 7679 0991
Fax: 020 7679 6583
Appointment
- Reader in Diabetes, Endocrinology and Obesity
- Metabolism & Experimental Therapeutics
- Div of Medicine
- Faculty of Medical Sciences
Joined UCL
01/09/2003
Research Themes
Research Summary
Complex interrelated neuronal circuits have developed in the mammalian brain to regulate many aspects of feeding behaviour. An increased understanding of how peripheral energy signals act upon these circuits to regulate food intake is essential for effective treatment of the current obesity crisis. We employ an holistic approach from molecular mechanisms to whole animal physiology and assessment of behaviour. Our approaches include in vitro cell line studies, quantitative gene expression analysis, neuroanatomical mapping studies, generation of tissue specific knock out mice and studies in healthy volunteers and obese patients.
We have shown that the gut hormone peptide YY (PYY) regulates feeding behaviour in rodents and humans and identified that the neuropeptide Y2 receptor is crucial for the anorectic effects of PYY. By generating mice-lacking PYY we have shown that this hormone plays a crucial role in the regulation of body weight. Moreover, we have shown that infusion of PYY reduces food intake in obese human subjects. More recently using fMRI in healthy male volunteers we have shown that PYY modulates neuronal activity within both homeostatic (hypothalamic and brainstem) and hedonic (orbitofrontal cortex) brain regions. We are currently investigating how whole brain circuits involved in homeostasis and reward respond to different stimuli depending on the nutritional status of the animal (fasted/fed/normal weight, obese).
Bariatric surgery is the most effective weight-loss treatment for morbidly obese patients ameliorating obesity co-morbidities and decreasing mortality. However, despite its widespread use, the mechanisms underlying the benefits of bariatric (weight loss) surgery are largely unknown. One of the research focuses of the group is to investigate how bariatric surgery results in marked appetite reduction and weight loss by studying the effects of this surgery (in rodents and humans) on peripheral energy signals and the neural circuits whichregulate feeding behaviour.
We have shown that the gut hormone peptide YY (PYY) regulates feeding behaviour in rodents and humans and identified that the neuropeptide Y2 receptor is crucial for the anorectic effects of PYY. By generating mice-lacking PYY we have shown that this hormone plays a crucial role in the regulation of body weight. Moreover, we have shown that infusion of PYY reduces food intake in obese human subjects. More recently using fMRI in healthy male volunteers we have shown that PYY modulates neuronal activity within both homeostatic (hypothalamic and brainstem) and hedonic (orbitofrontal cortex) brain regions. We are currently investigating how whole brain circuits involved in homeostasis and reward respond to different stimuli depending on the nutritional status of the animal (fasted/fed/normal weight, obese).
Bariatric surgery is the most effective weight-loss treatment for morbidly obese patients ameliorating obesity co-morbidities and decreasing mortality. However, despite its widespread use, the mechanisms underlying the benefits of bariatric (weight loss) surgery are largely unknown. One of the research focuses of the group is to investigate how bariatric surgery results in marked appetite reduction and weight loss by studying the effects of this surgery (in rodents and humans) on peripheral energy signals and the neural circuits whichregulate feeding behaviour.
Academic Background
| 2003 | PhD | Doctor of Philosophy | University of London |
| 2002 | MSc | Master of Science | To be updated |
| 1998 | MRCP | Member of the Royal College of Physicians | Royal College of Physicians |
| 1995 | MBBS | Bachelor of Medicine/Bachelor of Surgery | University of London |
| 1992 | BSc | Bachelor of Science | St Mary's Hospital Medical School |
